Ray Dalio's OGN Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 668,687 shares of Organon & Co. (OGN) worth $7.14 M, representing 0.03% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Ray Dalio has maintained this position in OGN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 480,251 shares. Largest reduction occurred in Q4 2024, reducing 185,149 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Organon & Co (OGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organon & Co (OGN) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2024 | +203,196 | New Buy | 203,196 | $19.13 |
| Q4 2024 | -185,149 | Reduce 91.12% | 18,047 | $14.92 |
| Q1 2025 | +50,250 | Add 278.44% | 68,297 | $14.89 |
| Q2 2025 | +120,139 | Add 175.91% | 188,436 | $9.68 |
| Q3 2025 | +480,251 | Add 254.86% | 668,687 | $10.68 |
Ray Dalio's Organon & Co Investment FAQs
Ray Dalio first purchased Organon & Co. (OGN) in Q3 2024, acquiring 203,196 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Organon & Co. (OGN) for 5 quarters since Q3 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Organon & Co. (OGN) was in Q3 2025, adding 668,687 shares worth $7.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 668,687 shares of Organon & Co. (OGN), valued at approximately $7.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Organon & Co. (OGN) represents approximately 0.03% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Organon & Co. (OGN) was 668,687 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.